200 related articles for article (PubMed ID: 22982754)
1. Subtle changes in TCRα CDR1 profoundly increase the sensitivity of CD4 T cells.
Lynch JN; Donermeyer DL; Weber KS; Kranz DM; Allen PM
Mol Immunol; 2013 Mar; 53(3):283-94. PubMed ID: 22982754
[TBL] [Abstract][Full Text] [Related]
2. Elongated TCR alpha chain CDR3 favors an altered CD4 cytokine profile.
Reynolds C; Chong D; Raynsford E; Quigley K; Kelly D; Llewellyn-Hughes J; Altmann D; Boyton R
BMC Biol; 2014 May; 12():32. PubMed ID: 24886643
[TBL] [Abstract][Full Text] [Related]
3. CD4 T cells selected by antigen under Th2 polarizing conditions favor an elongated TCR alpha chain complementarity-determining region 3.
Boyton RJ; Zaccai N; Jones EY; Altmann DM
J Immunol; 2002 Feb; 168(3):1018-27. PubMed ID: 11801634
[TBL] [Abstract][Full Text] [Related]
4. TCR recognition of the Hb(64-76)/I-Ek determinant: single conservative amino acid changes in the complementarity-determining region 3 dramatically alter antigen fine specificity.
Hsu BL; Donermeyer DL; Allen PM
J Immunol; 1996 Sep; 157(6):2291-8. PubMed ID: 8805626
[TBL] [Abstract][Full Text] [Related]
5. A new twist in TCR diversity revealed by a forbidden alphabeta TCR.
McBeth C; Seamons A; Pizarro JC; Fleishman SJ; Baker D; Kortemme T; Goverman JM; Strong RK
J Mol Biol; 2008 Feb; 375(5):1306-19. PubMed ID: 18155234
[TBL] [Abstract][Full Text] [Related]
6. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
Wither JE; Vukusic B
J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
[TBL] [Abstract][Full Text] [Related]
7. Effects of complementarity determining region mutations on the affinity of an alpha/beta T cell receptor: measuring the energy associated with CD4/CD8 repertoire skewing.
Manning TC; Parke EA; Teyton L; Kranz DM
J Exp Med; 1999 Feb; 189(3):461-70. PubMed ID: 9927508
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor (TCR)-peptide specificity overrides affinity-enhancing TCR-major histocompatibility complex interactions.
Cole DK; Miles KM; Madura F; Holland CJ; Schauenburg AJ; Godkin AJ; Bulek AM; Fuller A; Akpovwa HJ; Pymm PG; Liddy N; Sami M; Li Y; Rizkallah PJ; Jakobsen BK; Sewell AK
J Biol Chem; 2014 Jan; 289(2):628-38. PubMed ID: 24196962
[TBL] [Abstract][Full Text] [Related]
9. The activation threshold of CD4+ T cells is defined by TCR/peptide-MHC class II interactions in the thymic medulla.
Stephen TL; Tikhonova A; Riberdy JM; Laufer TM
J Immunol; 2009 Nov; 183(9):5554-62. PubMed ID: 19843939
[TBL] [Abstract][Full Text] [Related]
10. Complementarity-determining region 1 sequence requirements drive limited V alpha usage in response to influenza hemagglutinin 307-319 peptide.
Brawley JV; Concannon P
J Immunol; 2002 Apr; 168(8):3894-901. PubMed ID: 11937544
[TBL] [Abstract][Full Text] [Related]
11. A single T cell receptor bound to major histocompatibility complex class I and class II glycoproteins reveals switchable TCR conformers.
Yin L; Huseby E; Scott-Browne J; Rubtsova K; Pinilla C; Crawford F; Marrack P; Dai S; Kappler JW
Immunity; 2011 Jul; 35(1):23-33. PubMed ID: 21683626
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence for TCR-intrinsic specificity for MHCII.
Parrish HL; Deshpande NR; Vasic J; Kuhns MS
Proc Natl Acad Sci U S A; 2016 Mar; 113(11):3000-5. PubMed ID: 26831112
[TBL] [Abstract][Full Text] [Related]
14. Alpha beta TCRs differ in the degree of their specificity for the positively selecting MHC/peptide ligand.
Kraj P; Pacholczyk R; Ignatowicz L
J Immunol; 2001 Feb; 166(4):2251-9. PubMed ID: 11160279
[TBL] [Abstract][Full Text] [Related]
15. Control of MHC restriction by TCR Valpha CDR1 and CDR2.
Sim BC; Zerva L; Greene MI; Gascoigne NR
Science; 1996 Aug; 273(5277):963-6. PubMed ID: 8688082
[TBL] [Abstract][Full Text] [Related]
16. A role for accessibility to self-peptide-self-MHC complexes in intrathymic negative selection.
Viret C; Sant'Angelo DB; He X; Ramaswamy H; Janeway CA
J Immunol; 2001 Apr; 166(7):4429-37. PubMed ID: 11254698
[TBL] [Abstract][Full Text] [Related]
17. Restricted TCR-alpha CDR3 diversity disadvantages natural regulatory T cell development in the B6.2.16 beta-chain transgenic mouse.
Singh Y; Ferreira C; Chan AC; Dyson J; Garden OA
J Immunol; 2010 Sep; 185(6):3408-16. PubMed ID: 20713881
[TBL] [Abstract][Full Text] [Related]
18. Recognition of a specific self-peptide: self-MHC class II complex is critical for positive selection of thymocytes expressing the D10 TCR.
Dao T; Blander JM; Sant'Angelo DB
J Immunol; 2003 Jan; 170(1):48-54. PubMed ID: 12496382
[TBL] [Abstract][Full Text] [Related]
19. Distinct CDR3 conformations in TCRs determine the level of cross-reactivity for diverse antigens, but not the docking orientation.
Jones LL; Colf LA; Stone JD; Garcia KC; Kranz DM
J Immunol; 2008 Nov; 181(9):6255-64. PubMed ID: 18941216
[TBL] [Abstract][Full Text] [Related]
20. Competition for specific intrathymic ligands limits positive selection in a TCR transgenic model of CD4+ T cell development.
Wong P; Goldrath AW; Rudensky AY
J Immunol; 2000 Jun; 164(12):6252-9. PubMed ID: 10843678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
